SAM
LGND icon

Securian Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Securian Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,409
Closed -$197K – 990
2021
Q2 		$197K Sell
2,409
-161
-6% -$13.4K ﹤0.01% 971
2021
Q1 		$244K Buy
2,570
+161
+7% +$15.2K 0.01% 947
2020
Q4 		$149K Hold
2,409
– – ﹤0.01% 971
2020
Q3 		$143K Sell
2,409
-161
-6% -$11K ﹤0.01% 983
2020
Q2 		$179K Sell
2,570
-160
-6% -$10.1K ﹤0.01% 947
2020
Q1 		$124K Sell
2,730
-160
-6% -$9.07K ﹤0.01% 963
2019
Q4 		$188K Sell
2,890
-529
-15% -$35.4K ﹤0.01% 987
2019
Q3 		$212K Sell
3,419
-396
-10% -$24.9K ﹤0.01% 966
2019
Q2 		$272K Sell
3,815
-160
-4% -$11.8K 0.01% 939
2019
Q1 		$312K Sell
3,975
-161
-4% -$12.2K 0.01% 916
2018
Q4 		$350K Buy
+4,136
New +$441K 0.01% 856

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Securian Asset Management's LGND Position: Q3 2021 in Review

Securian Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 2,409 shares — an estimated $197K sold.

Securian Asset Management first reported a position in LGND in Q4 2018 and held it in 11 quarters. The position peaked at $350K in Q4 2018. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • Securian Asset Management reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Securian Asset Management sold 2,409 Ligand Pharmaceuticals shares in Q3 2021, an estimated $197K.
  • Securian Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2018 and held it in 11 quarters.
  • Securian Asset Management's Ligand Pharmaceuticals position peaked at $350K in Q4 2018.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Securian Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.